NO870998D0 - PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES. - Google Patents

PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES.

Info

Publication number
NO870998D0
NO870998D0 NO870998A NO870998A NO870998D0 NO 870998 D0 NO870998 D0 NO 870998D0 NO 870998 A NO870998 A NO 870998A NO 870998 A NO870998 A NO 870998A NO 870998 D0 NO870998 D0 NO 870998D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
new therapeutic
therapeutic active
acetamide derivatives
Prior art date
Application number
NO870998A
Other languages
Norwegian (no)
Other versions
NO870998L (en
Inventor
Jacques Comarmond
Thomas Purcell
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO870998D0 publication Critical patent/NO870998D0/en
Publication of NO870998L publication Critical patent/NO870998L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
NO870998A 1986-03-12 1987-03-11 METHOD OF PROGRESS FOR THE MANUFACTURE OF NEW, THERAPEUTICALLY ACTIVE ACETAMIDE DERIVATIVES. NO870998L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8603489A FR2595695B1 (en) 1986-03-12 1986-03-12 DERIVATIVES OF N - (((HYDROXY-2 PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
NO870998D0 true NO870998D0 (en) 1987-03-11
NO870998L NO870998L (en) 1987-09-14

Family

ID=9333030

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870998A NO870998L (en) 1986-03-12 1987-03-11 METHOD OF PROGRESS FOR THE MANUFACTURE OF NEW, THERAPEUTICALLY ACTIVE ACETAMIDE DERIVATIVES.

Country Status (12)

Country Link
EP (1) EP0239461A1 (en)
JP (1) JPS62230767A (en)
KR (1) KR870008842A (en)
AU (1) AU6991087A (en)
DK (1) DK123987A (en)
FI (1) FI871067A (en)
FR (1) FR2595695B1 (en)
HU (1) HUT43820A (en)
IL (1) IL81858A0 (en)
NO (1) NO870998L (en)
PT (1) PT84452B (en)
ZA (1) ZA871766B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS103091A3 (en) * 1991-04-12 1992-10-14 Ustav Organicke Chemie A Bioch Protected substituted benzhydrylamines as shoulders for the synthesis ofpeptides on solid phase, process of their preparation and use
DE69435011T2 (en) * 1993-06-21 2008-10-23 Aventis Pharmaceuticals Inc. Selectively cleavable linkers based on a methionine and an ester group
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
CA2285659A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
WO1998046628A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
EP0975625A1 (en) * 1997-04-14 2000-02-02 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
JP2006522742A (en) * 2003-04-08 2006-10-05 ニューロームド テクノロジーズ、インク． A group of calcium channel inhibitors consisting of benzhydryl groups spaced from piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319338A1 (en) * 1975-08-01 1977-02-25 Synthelabo NEW A-PHENYL BENZYLIDENIC DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
FR2516509B1 (en) * 1981-11-18 1985-07-26 Synthelabo BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
HUT43820A (en) 1987-12-28
JPS62230767A (en) 1987-10-09
FI871067A0 (en) 1987-03-11
NO870998L (en) 1987-09-14
IL81858A0 (en) 1987-10-20
PT84452B (en) 1989-03-17
PT84452A (en) 1987-04-01
FI871067A (en) 1987-09-13
DK123987A (en) 1987-09-13
AU6991087A (en) 1987-09-17
KR870008842A (en) 1987-10-21
EP0239461A1 (en) 1987-09-30
DK123987D0 (en) 1987-03-11
FR2595695A1 (en) 1987-09-18
ZA871766B (en) 1987-09-01
FR2595695B1 (en) 1988-12-02

Similar Documents

Publication Publication Date Title
NO166639C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED BASIC 2-AMINOTETRALINES.
NO871266L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES.
NO904694D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES.
NO901684L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-SUBSTITUTED-2-OXINDOL DERIVATIVES.
NO870526L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES.
NO905201D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOFURAN DERIVATIVES.
NO871879D0 (en) PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE Heterocyclic Compounds.
NO880182L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2-DIHYDRO-3H-INDAZOL-3-ON DERIVATIVES.
NO166362C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE POLYAMINE DERIVATIVES.
NO874032L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES.
NO845176L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4H-3,1-BENZOKSAZIN-4-ON DERIVATIVES
NO891191D0 (en) PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTICALLY EFFECTIVE CATECHOLD DERIVATIVES.
NO870998D0 (en) PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES.
NO883122D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLAMIDE DERIVATIVES.
NO875488L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKANSULPHONANILIDE DERIVATIVES.
NO900697D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES.
NO873108D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-BENZODIAZEPINES.
NO873835D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOCYCLIC PYRIDINES.
NO893784L (en) PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES.
NO891025D0 (en) PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE SIALOSYLYL GYCERIDES.
NO871907D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENAMIDE DERIVATIVES.
NO165917C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIAMINO-2,2-DIFLUORHEX-5-YN.
NO900972D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NAFTALEN DERIVATIVES.
NO900942D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AZACYCLOOKTADIEN DERIVATIVES.
NO165800C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE ERGOLEND DERIVATIVES.